United States v. Joseph Mehl ( 2019 )


Menu:
  •                                                                    NOT PRECEDENTIAL
    UNITED STATES COURT OF APPEALS
    FOR THE THIRD CIRCUIT
    No. 17-2954
    UNITED STATES OF AMERICA
    v.
    JOSEPH MEHL
    a/k/a
    JOSEPH MONTANERO
    Joseph Mehl,
    Appellant
    APPEAL FROM THE UNITED STATES DISTRICT COURT
    FOR THE EASTERN DISTRICT OF PENNSYLVANIA
    (D.C. No. 2-15-cr-00021-005)
    District Judge: Honorable Nitza I. Quinones Alejandro
    Submitted Under Third Circuit L.A.R. 34.1(a)
    (Submitted: January 18, 2019)
    Before: GREENAWAY, JR., SHWARTZ, and PORTER Circuit Judges.
    (Opinion Filed: August 15, 2019)
    OPINION *
    *
    This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7
    does not constitute binding precedent.
    GREENAWAY, JR., Circuit Judge.
    This case arises from a drug conspiracy (a “pill mill”) in which Appellant Joseph
    Mehl and others referred illegitimate “pseudo-patients” to a doctor who illegally
    prescribed opioids for profit. After Mehl entered an open plea of guilty of conspiracy to
    distribute controlled substances in violation of 
    21 U.S.C. § 846
    , the District Court
    sentenced him to 180 months’ imprisonment, imposed a three-year period of supervised
    release, and ordered him to pay a special assessment of $100. Mehl challenges the
    District Court’s sentence, arguing that the District Court erred in calculating the drug
    quantity attributable to him, erred in finding that Mehl was responsible for certain acts
    that occurred after his alleged withdrawal from the conspiracy in July 2013, and thus
    imposed a procedurally unreasonable sentence. For the reasons detailed below, we will
    affirm the District Court’s sentence.
    Mehl met William O’Brien III, a doctor of osteopathic medicine, after he was
    involved in an automobile accident in June 2011. Mehl began sending pseudo-patients to
    O’Brien for prescriptions of controlled substances. From March 2012 through January
    2015, O’Brien sold medically unnecessary prescriptions for medications—including
    oxycodone, methadone, and Xanax—to pseudo-patients with the help of Mehl and the
    other co-conspirators. O’Brien also provided prescriptions for narcotics to drug
    traffickers, many of whom were members of the Pagans Motorcycle Club of Philadelphia
    (“Pagans”). Sam Nocille, president of the Pagans, devised a scheme whereby members
    2
    of the gang would fill the prescriptions supplied by O’Brien, and sell them on the street
    for cash. Nocille received a kickback from the proceeds of the sale of the illegally
    obtained drugs until his death in January 2014.
    The parties contest the extent of Mehl’s involvement in the pill mill. According to
    the Government, Mehl’s role was to recruit pseudo-patients, accompany them to the
    pharmacy to fill their prescriptions, help collect payments from the illegal sale of those
    prescriptions, and pay a portion of the proceeds to Nocille. The Government argues that
    Mehl brought in a pseudo-patient group consisting of several individuals, including his
    wife, ex-wife, and brother-in-law, each of whom procured medically unnecessary
    prescriptions from O’Brien. The parties agree that in the early stages of the conspiracy,
    Mehl facilitated the introduction of members of the Pagans to O’Brien, but Mehl argues
    that his role in the conspiracy was only marginal. In total, Mehl was found responsible
    for the marijuana equivalent of 15,383.53 kilograms of controlled substances.
    On July 14, 2015, Mehl and eight codefendants (including O’Brien) were charged
    with conspiracy to distribute Schedule II controlled substances, in violation of 
    21 U.S.C. § 846
     (Count Two). On April 14, 2016, Mehl entered an open guilty plea in the United
    States District Court for the Eastern District of Pennsylvania to the Count Two
    conspiracy charge. The District Court sentenced Mehl to 180 months’ imprisonment,
    three years of supervised release, and ordered him to pay a special assessment of $100.
    3
    1
    Mehl argues that the District Court’s sentence was procedurally unreasonable on
    three grounds. First, according to Mehl, the District Court miscalculated the drug
    quantity attributable to him for sentencing purposes; therefore, his base offense level of
    34, his final adjusted offense level of 37, and his advisory Sentencing Guideline range of
    262-327 months of incarceration were incorrect. 2 Second, Mehl argues that the District
    Court erred in finding that Mehl was responsible for certain acts that occurred after his
    alleged withdrawal from the conspiracy in July 2013. Third, Mehl asserts that the
    District Court failed to consider the nature and circumstances of his offense as required
    by 
    18 U.S.C. § 3553
    (a)(1).
    We review a district court’s “application of the Guidelines to the facts for abuse of
    discretion and its factual findings for clear error.” United States v. Blackmon, 
    557 F.3d 113
    , 118 (3d Cir. 2009) (internal quotation marks and citations omitted). “The
    Sentencing Guidelines are now advisory, but a sentence will be found procedurally
    unreasonable when a district court fails to calculate accurately the sentencing range
    suggested by the Guidelines.” 
    Id.
     (citing Gall v. United States, 
    552 U.S. 38
    , 49-50
    (2007)). “The party challenging the sentence bears the ultimate burden of proving its
    1
    The District Court had jurisdiction pursuant to 
    18 U.S.C. § 3231
     and we have
    jurisdiction under 
    28 U.S.C. § 1291
     and 
    18 U.S.C. § 3742
    (a).
    2
    Because the statutory maximum term of imprisonment for Mehl’s offense was
    twenty years, however, the recommended Guidelines sentence was capped at 240 months.
    4
    unreasonableness, and we accord great deference to a district court’s choice of final
    sentence.” United States v. Lessner, 
    498 F.3d 185
    , 204 (3d Cir. 2007) (internal citations
    omitted).
    Under the Guidelines, relevant conduct in a conspiracy includes “all acts and
    omissions committed, aided, abetted, counseled, commanded, induced, procured, or
    willfully caused by the defendant; and . . . all reasonably foreseeable acts and omissions
    of others in furtherance of the jointly undertaken criminal activity.” U.S.S.G.
    § 1B1.3(a)(1)(A), (a)(1)(B). As the commentary to § 1B1.3 explains, a person convicted
    of conspiracy to distribute controlled substances “is accountable for all quantities of
    contraband with which he was directly involved and . . . all reasonably foreseeable
    quantities of contraband that were within the scope of the criminal activity that he jointly
    undertook.” United States v. Iglesias, 
    535 F.3d 150
    , 160 (3d Cir. 2008) (omission in
    original) (emphasis omitted) (quoting U.S.S.G. § 1B1.3 cmt. n.2). However, “when a
    defendant is convicted of drug distribution, ordinarily a district court should exclude from
    the total drug quantity any amount possessed for his personal consumption.” Id.
    (citing Jansen v. United States, 
    369 F.3d 237
    , 249 (3d Cir. 2004)).
    According to Mehl, the District Court erroneously determined that he was
    responsible for the prescriptions of patients without sufficient material evidence to
    support such a finding. We disagree. The District Court made the specific finding that
    Mehl brought several different categories of individuals into the conspiracy, each of
    whom contributed to the use or sale of illegal substances. To support this finding, the
    5
    District Court relied on Mehl’s own post-arrest admissions to the authorities, patient
    charts seized from O’Brien’s office, testimony from several witnesses, and a list of
    recruited patients offered by a former pill mill employee. Furthermore, the District Court
    attributed 50% of the oxycodone 30 mg pills to Mehl’s personal use, illustrating that it
    accepted—albeit in part—Mehl’s argument that he struggled with substance abuse and
    had nerve damage, and obtained pills from O’Brien for personal use. See United States v.
    Miele, 
    989 F.2d 659
    , 665-66 (3d Cir. 1993) (“Where there is other evidence to support
    the higher end of an estimated range, the court may certainly rely on the higher
    estimate.”). The quantity of drugs that the District Court attributed to Mehl was
    reasonable and supported by the record. Therefore, the District Court’s calculation of
    Mehl’s offense level under the advisory Sentencing Guidelines was not erroneous.
    Mehl also argues that the District Court erred by declining to conclude that Mehl
    withdrew from the conspiracy in July 2013. To establish withdrawal, Mehl “must present
    evidence of some affirmative act of withdrawal on his part, typically either a full
    confession to the authorities or communication to his co-conspirators that he has
    abandoned the enterprise and its goals.” United States v. Steele, 
    685 F.2d 793
    , 803-04
    (3d Cir. 1982) (citations omitted). Mehl did not present this evidence. Instead, he
    contends that the purpose of the conspiracy was for him to obtain pills to support his
    addiction, and since the record suggests that he stopped receiving pills in July 2013, the
    record also supports his argument that he withdrew from the conspiracy in July 2013.
    Mehl’s characterization overlooks evidence in the record, which shows that the pill mill
    6
    conspiracy in which he was involved was much larger than a simple exchange between
    Mehl and O’Brien for prescription substances. The District Court found, based on
    evidence in the record, that Mehl was responsible for bringing several individuals into the
    pill mill conspiracy—individuals who continued to receive pills and sell them well after
    July 2013. Evidence in the record also supports the District Court’s finding that Mehl
    offered to help Nocille collect on proceeds from the scheme in January 2014. Taken
    together, the record does not support Mehl’s argument that the District Court erred in
    attributing drugs that were obtained and sold after his alleged withdrawal.
    Mehl’s argument that the District Court failed to properly to consider the
    § 3553(a)(1) factors is similarly unconvincing. “Ultimately, ‘[t]he touchstone of
    “reasonableness” is whether the record as a whole reflects rational and meaningful
    consideration of the factors enumerated in 
    18 U.S.C. § 3553
    (a).’” United States v. Tomko,
    
    562 F.3d 558
    , 568 (3d Cir. 2009) (quoting United States v. Grier, 
    475 F.3d 556
    , 571 (3d
    Cir. 2007) (en banc)). During the sentencing hearing, the District Court expressly took
    the § 3553(a) sentencing factors into consideration. Under the Sentencing Guidelines,
    Mehl was eligible for 240 months’ imprisonment; however, based on “the arguments for
    a variance, . . . [Mehl’s] own allocution, [and] the relevant [§] 3553(a) factors,” the
    District Court sentenced Mehl to a term of 180 months’ imprisonment. SA 240. It is
    manifest that the District Court considered the relevant sentencing factors, therefore
    Mehl’s argument is without merit.
    7
    For the foregoing reasons, we will affirm the District Court’s sentence.
    8